#USA #New York #healthcare #CriticalPoint #Roger Kahn

CriticalPoint Strengthens Healthcare Investment Banking

CriticalPoint, a leading provider of customized financial solutions that combine the strengths of Investment Banking and Private Capital, has announced a significant expansion of its healthcare investment banking team with the hiring of Roger C. Kahn as Managing Director. This strategic move, which bolsters the firm's presence on the East Coast, is expected to enhance its capabilities in executing mergers and acquisitions as well as financing transactions within the healthcare sector.

Mr. Kahn brings an impressive portfolio of over 40 years of expertise in the field, having successfully completed more than 120 transactions worth over $12 billion. His specialization in healthcare investment banking spans more than 25 years, during which he has developed deep knowledge in various areas, including medical devices, specialty pharmaceuticals, biotechnology, lab services, healthcare IT, and healthcare services.

Prior to joining CriticalPoint, Mr. Kahn held the position of Managing Director at FTI Capital Advisors, where he played a vital role in major transactions, such as the sale of Avantik to Water Street Healthcare Partners and Grignard Company to AAVIN. His career also includes notable contributions at Capstone Headwaters, where he led several key healthcare transactions, including the sale of Sani-Tech West to 3i Group and Aspen Medical Products to Cortec Group. Mr. Kahn's earlier work experience features various senior roles in reputable firms, including Burnham Securities and CIBC Oppenheimer, further underlining his extensive background in capital raising and advisory services.

Matt Young, Founder and CEO of CriticalPoint, emphasized Mr. Kahn's vast experience and strong relationships in the healthcare industry as crucial assets for the firm's growth trajectory: "Roger's extensive healthcare experience and long-standing relationships across sponsors and strategic buyers make him an exceptional addition to CriticalPoint. Adding a tenured banker like Roger strengthens our ability to scale our healthcare practice. His proven experience leading complex transactions and delivering outcomes across a broad range of healthcare sub-sectors will be instrumental as we deepen our capabilities and continue our growth in the New York market."

Mr. Kahn expressed his enthusiasm for joining CriticalPoint, highlighting the firm's integrated platform as a crucial element for delivering differentiated outcomes for healthcare clients: "I am delighted to be joining CriticalPoint at this exciting juncture in the firm's growth trajectory. The firm's integrated platform, including buy-side and sell-side M&A expertise, strong sponsor and strategic relationships, and capital raising capabilities, creates a compelling opportunity to deliver differentiated outcomes for our healthcare clients. I look forward to bringing my extensive experience navigating complex healthcare deals to the growth of our practice."

The appointment of Mr. Kahn is a testament to CriticalPoint's commitment to enhancing its sector expertise and expanding its footprint in the New York market. This follows the recent hiring of Jerry Levin as Managing Director, who will focus on special situations capabilities within the firm.

About CriticalPoint: CriticalPoint provides tailored financial solutions through a platform that expertly blends the best of Investment Banking and Private Capital. Founded in 2012 by seasoned M&A professionals with a passion for deal-making, CriticalPoint is noted for its profound expertise in mergers and acquisitions, capital markets, and valuation advisory, as well as its focus on corporate divestitures and special situations. When stakeholders face defining moments across various industries, they depend on CriticalPoint's proven track record and in-depth knowledge to navigate their challenges effectively.